X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Indian Stock Market News, Equity Market and Sensex Today in India | Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Indian stock markets open in green
Wed, 31 Dec 09:30 am

The major Asian stock markets have opened the day on mixed note with Japan (down 1.6%) and Korea (down 0.6%) leading the losses. However, stock markets in China (up 0.7%) and Hong Kong (up 0.4%) have opened on a positive note. The Indian stock markets have opened on a positive note. Most of the sectoral indices have opened in the green with metal and oil and gas stocks leading the pack of gainers.

The Sensex today is up by around 40 points (0.13%), while the NSE-Nifty is up by about 15 points (0.17%). The mid cap and small cap stocks have also opened firm with BSE Mid Cap index and BSE Small Cap index up by 0.44% and 0.30% respectively. The rupee is currently trading at Rs 63.74 to the US dollar.

As per a financial daily, the government is pushing the state-run oil marketing firms to pass on the benefit of falling global oil prices to consumers. As a result the petrol and diesel prices are expected to get cheaper. While the price reductions may not be very sharp, state-run refiners are reluctant to bring down the rates, since they want to retain some margins to make up for their inventory losses which have bloated up to Rs 100 bn.

Most of the stocks from Indian pharma sector have opened the day on a firm note, with Indoco Remedies and Natco Pharma leading the pack of gainers. Lupin Ltd, announced today that it has received tentative approval for its Darunavir Ethanolate Tablets 75 mg, 150 mg, 300 mg, 400 mg, 600 mg and 800 mg from the USFDA. The said drug is equivalent to Janssen's Prezista, which is indicated for HIV- 1 infections. The market size of the drug is US$ 1.2 bn annually. The earliest patent expiry of the drug is in Dec 2015. Further, Lupin has received tentative approval, so the company can launch the drug once the final approval is received.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

Read the latest Market Commentary

Equitymaster requests your view! Post a comment on "Indian stock markets open in green". Click here!

  

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

S&P BSE HEALTHCARE


Nov 24, 2017 03:37 PM

S&P BSE HEALTHCARE 5-YR ANALYSIS

COMPARE COMPANY

MARKET STATS